Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Civacir receives orphan drug status for prevention of hepatitis C

Dec. 10, 2002

First phase III alvimopan trial in postoperative ileus completes enrollment

Dec. 10, 2002

FDA approves Pegasys and Copegus combination therapy in hepatitis C

Dec. 5, 2002

Senju claims novel compounds with potential in reflux esophagitis

Dec. 5, 2002

Novartis initiates ZENSAA study of Zelmac in IBS

Dec. 3, 2002

Nabi files BLA for use of Nabi-HB in liver transplant patients

Nov. 29, 2002

Positive opinion issued in E.U. for Hepsera

Nov. 26, 2002

Alicaforsen enters new phase II trial in active ulcerative colitis

Nov. 25, 2002

Lotronex available under restricted use for women with diarrhea-predominant IBS

Nov. 25, 2002

BioPartners to use Durect technology to produce sustained-release interferon alfa

Nov. 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...